Medicamen Biotech
MEDICAMEQ · Pharma > Pharmaceuticals & Drugs · Chairman: Rahul Bishnoi Listing date: Oct. 28, 2021

Stock Price vs Company Growth
1d
2.7%
1w
7.3%
1m
11.5%
3m
7.2%
6m
22.0%
1y
26.2%
all
7.0%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec16Dec18Jun20Dec21Jun23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

426 2.7%
398
560
Company Overview

Sales
180 Cr
Growth: 10.9%
Profit after Tax
8.41 Cr
Growth: 20.7%
Small Cap
542 Cr
P/E: 81.2x
Industry P/E: 30.9x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 180
Growth 10.9%
EBITDA 11.8%
P/S 3.0x
Dividend 0.2%
P/E 81.2x
Book Value ₹ 10
PEG Ratio 7.6x
ROE 66.1%
P/B N/A
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Sep21Sep22Dec22Sep23Mar24Jun24Sep24Dec24
Promoters
Created with Highcharts 8.2.2Sep21Sep22Dec22Sep23Mar24Jun24Sep24Dec24
Others
Created with Highcharts 8.2.2Sep21Sep22Dec22Sep23Mar24Jun24Sep24Dec24
Increase    Decrease    No change
Company Profile Detailed

Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.
Investors (2)
Followers (1)